Detalhe da pesquisa
1.
A Platform for the Generation of Site-Specific Antibody-Drug Conjugates That Allows for Selective Reduction of Engineered Cysteines.
Bioconjug Chem
; 31(9): 2136-2146, 2020 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32697078